What's new? Log in Free sign up

Fortrea (FTRE)

Company Profile

Company profile

Ticker

FTRE

Exchange

Location

Fiscal year end

Sector

Professional, Scientific, and Technical Services > Testing Laboratories

Industry (SIC)

Services - Medical Laboratories

Quest Diagnostics • Laboratory Corp. Of America • Radnet • Akumin • Burning Rock Biotech • Guardant Health • Genomic Health • Exact Sciences • Invitae • Natera ...

Former names

Silver Spinco Inc.

SEC CIK

Corporate docs

Plans of Reorganization

Material Contracts & Credit Agreements

Subsidiaries Lists

IRS number

922796441

FTRE stock data

1M 1Y 5Y

Latest filings (excl ownership)

View all

Regulation FD Disclosure

Quarterly report

13 Nov 23

Fortrea Reports Third Quarter 2023 Results

Fortrea Reports Second-Quarter 2023 Results and Provides Full-Year 2023 Guidance

Departure of Directors or Certain Officers

Quarterly report

Fortrea Reports Second-Quarter 2023 Results Company and Provides Full-Year 2023 Guidance

Entry into a Material Definitive Agreement

Entry into a Material Definitive Agreement

Transcripts

Earnings call transcript

Earnings call transcript

Latest ownership filings

View all

Starboard Value LP

PETER M NEUPERT

Jill G. Mcconnell

VANGUARD GROUP INC

Amanda M. Warren

R ANDREW ECKERT

Financial summary

Financial statements Chart FTRE financial data

Quarter (USD)	Sep 23	Jun 23
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Cash burn rate (est.)	Burn method: Change in cash		Burn method: Operating income		Burn method: FCF (opex + capex)
Cash on hand (at last report)	107.50 mm		107.50 mm		107.50 mm
Cash burn (monthly)	2.27 mm		5.97 mm		(no burn)
Cash used (since last report)	5.15 mm		13.57 mm		n/a
Cash remaining	102.35 mm		93.93 mm		n/a
Runway (months of cash)	45.2		15.7		n/a

Beta Read what these cash burn values mean

Financial data from Fortrea earnings reports.

Institutional ownership, Q3 2023

FTRE institutional ownership history Ownership history

98.3% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	392	31	+1164.5%
Opened positions	371	31	+1096.8%
Closed positions	10	0	NEW
Increased positions	14	0	NEW
Reduced positions	5	0	NEW

13F shares	Current	Prev Q	Change
Total value	2.47 tn	96.42 bn	+2464.1%
Total shares	87.27 mm	2.91 mm	+2900.1%
Total puts	88.30 k	13.60 k	+549.3%
Total calls	204.90 k	10.30 k	+1889.3%
Total put/call ratio	0.4	1.3	-67.4%

Largest owners	Shares	Value	Change
BLK Blackrock	16.93 mm	$483.89 bn	NEW
Vanguard	10.00 mm	$285.79 bn	NEW
Sessa Capital IM	5.28 mm	$150.81 bn	NEW
Boston Partners	4.21 mm	$120.26 bn	+323.1%
Gates Capital Management	3.94 mm	$112.66 bn	+255.7%
UBS UBS Group AG - Registered Shares	3.76 mm	$107.45 bn	+5446637.7%
Alliancebernstein	3.21 mm	$91.87 bn	NEW
STT State Street	2.80 mm	$80.13 bn	NEW
Citadel Advisors	2.23 mm	$63.68 bn	NEW
Beck Mack & Oliver	2.03 mm	$58.08 bn	+7565.7%

Largest transactions	Shares	Bought/sold	Change
BLK Blackrock	16.93 mm	+16.93 mm	NEW
Vanguard	10.00 mm	+10.00 mm	NEW
Sessa Capital IM	5.28 mm	+5.28 mm	NEW
UBS UBS Group AG - Registered Shares	3.76 mm	+3.76 mm	+5446637.7%
Alliancebernstein	3.21 mm	+3.21 mm	NEW
Boston Partners	4.21 mm	+3.21 mm	+323.1%
Gates Capital Management	3.94 mm	+2.83 mm	+255.7%
STT State Street	2.80 mm	+2.80 mm	NEW
Citadel Advisors	2.23 mm	+2.23 mm	NEW
Beck Mack & Oliver	2.03 mm	+2.00 mm	+7565.7%

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Recent insider trades

FTRE insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
23 Aug 23	Pike Thomas	Common Stock	Buy	Acquire P	No	No	25.232	20,000	504.64 k	20,000
23 Aug 23	Peter M Neupert	Common Stock	Buy	Acquire P	No	No	25.296	11,000	278.26 k	21,996
17 Aug 23	Jill G. Mcconnell	RSU Common Stock	Grant	Acquire A	No	No	0	33,937	0.00	99,607
17 Aug 23	Mark A. Morais	RSU Common Stock	Grant	Acquire A	No	No	0	33,937	0.00	95,674
17 Aug 23	Pike Thomas	RSU Common Stock	Grant	Acquire A	No	No	0	377,074	0.00	497,742
17 Aug 23	Pike Thomas	NQSO Common Stock	Grant	Acquire A	No	No	26.52	799,272	21.20 mm	799,272

Data from 3, 4 and 5 filings. Values as filed, not updated for current price.

News

From Benzinga Pro

The Latest Analyst Ratings for Fortrea Holdings

Evercore ISI Group Upgrades Fortrea Holdings to Outperform, Raises Price Target to $36

Evercore ISI Group analyst Elizabeth Anderson upgrades Fortrea Holdings (NASDAQ:FTRE) from In-Line to Outperform and raises the price target from $32 to $36.

Why Is Inflammation Disease Focused Acelyrin Stock Trading Lower Today?

Acelyrin Inc (NASDAQ: SLRN) updated its izokibep clinical development program, including its ongoing global Phase 2b/3 trial for izokibep in

Barclays Upgrades Fortrea Holdings to Overweight, Raises Price Target to $38

Monday.Com Reports Q3 Beat, Joins Fortrea Holdings, Henry Schein And Other Big Stocks Moving Higher On Monday

Press releases

From Benzinga Pro

Fortrea Announces AI-Driven Partnership with Medidata to Increase Diversity in Clinical Trials

DURHAM, N.C., Nov. 20, 2023 (GLOBE NEWSWIRE) -- Fortrea (NASDAQ:FTRE), a leading global contract research organization (CRO), today announced a partnership with Medidata, a Dassault Systèmes company and leading

Fortrea Reports Third Quarter 2023 Results

For the three months ended September 30, 2023: Revenues of $776.4 millionGAAP net loss of $13.1 millionAdjusted EBITDA of $70.5 millionGAAP and adjusted diluted earnings (loss) per share of ($0.15) and $0.24,

Starboard Value Issues Presentation Delivered at 13D Monitor's 2023 Active-Passive Investor Summit

Starboard Value LP (together with its affiliates, "Starboard" or "we") today announced that Jeffrey Smith, the firm's Chief Executive Officer and Chief Investment Officer, delivered a presentation at the 2023

Fortrea Appoints Life Science Executive Dr. John Doyle to Lead Consulting Team

Fortrea Announces Date for Third Quarter 2023 Financial Results and Conference Call

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.